222 related articles for article (PubMed ID: 29716531)
1. Generation of a PAX6 knockout glioblastoma cell line with changes in cell cycle distribution and sensitivity to oxidative stress.
Hegge B; Sjøttem E; Mikkola I
BMC Cancer; 2018 May; 18(1):496. PubMed ID: 29716531
[TBL] [Abstract][Full Text] [Related]
2. Role of miR-223/paired box 6 signaling in temozolomide chemoresistance in glioblastoma multiforme cells.
Cheng Q; Ma X; Cao H; Chen Z; Wan X; Chen R; Peng R; Huang J; Jiang B
Mol Med Rep; 2017 Feb; 15(2):597-604. PubMed ID: 28035389
[TBL] [Abstract][Full Text] [Related]
3. microRNA-223 promotes the growth and invasion of glioblastoma cells by targeting tumor suppressor PAX6.
Huang BS; Luo QZ; Han Y; Li XB; Cao LJ; Wu LX
Oncol Rep; 2013 Nov; 30(5):2263-9. PubMed ID: 23970099
[TBL] [Abstract][Full Text] [Related]
4. MiR-223/PAX6 Axis Regulates Glioblastoma Stem Cell Proliferation and the Chemo Resistance to TMZ via Regulating PI3K/Akt Pathway.
Huang BS; Luo QZ; Han Y; Huang D; Tang QP; Wu LX
J Cell Biochem; 2017 Oct; 118(10):3452-3461. PubMed ID: 28332226
[TBL] [Abstract][Full Text] [Related]
5. Generation of Pax6-IRES-EGFP knock-in mouse via the cloning-free CRISPR/Cas9 system to reliably visualize neurodevelopmental dynamics.
Inoue YU; Morimoto Y; Hoshino M; Inoue T
Neurosci Res; 2018 Jul; 132():1-7. PubMed ID: 29391173
[TBL] [Abstract][Full Text] [Related]
6. PAX6 increases glioma cell susceptibility to detachment and oxidative stress.
Chang JY; Hu Y; Siegel E; Stanley L; Zhou YH
J Neurooncol; 2007 Aug; 84(1):9-19. PubMed ID: 17318412
[TBL] [Abstract][Full Text] [Related]
7. Suppressing Dazl modulates tumorigenicity and stemness in human glioblastoma cells.
Zhang F; Liu R; Zhang H; Liu C; Liu C; Lu Y
BMC Cancer; 2020 Jul; 20(1):673. PubMed ID: 32682409
[TBL] [Abstract][Full Text] [Related]
8. PAX6 suppresses growth of human glioblastoma cells.
Zhou YH; Wu X; Tan F; Shi YX; Glass T; Liu TJ; Wathen K; Hess KR; Gumin J; Lang F; Yung WK
J Neurooncol; 2005 Feb; 71(3):223-9. PubMed ID: 15735909
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of CDC2 expression inhibits proliferation, enhances apoptosis, and increases chemosensitivity to temozolomide in glioblastoma cells.
Zhou B; Bu G; Zhou Y; Zhao Y; Li W; Li M
Med Oncol; 2015 Jan; 32(1):378. PubMed ID: 25433945
[TBL] [Abstract][Full Text] [Related]
10. Characterizing the molecular mechanisms of acquired temozolomide resistance in the U251 glioblastoma cell line by protein microarray.
Lin J; Zuo J; Cui Y; Song C; Wu X; Feng H; Li J; Li S; Xu Q; Wei W; Qiu G; He H
Oncol Rep; 2018 May; 39(5):2333-2341. PubMed ID: 29565460
[TBL] [Abstract][Full Text] [Related]
11. p53 upregulated modulator of apoptosis sensitizes drug-resistant U251 glioblastoma stem cells to temozolomide through enhanced apoptosis.
Miao W; Liu X; Wang H; Fan Y; Lian S; Yang X; Wang X; Guo G; Li Q; Wang S
Mol Med Rep; 2015 Jun; 11(6):4165-73. PubMed ID: 25625235
[TBL] [Abstract][Full Text] [Related]
12. Increased Expression of System xc- in Glioblastoma Confers an Altered Metabolic State and Temozolomide Resistance.
Polewski MD; Reveron-Thornton RF; Cherryholmes GA; Marinov GK; Cassady K; Aboody KS
Mol Cancer Res; 2016 Dec; 14(12):1229-1242. PubMed ID: 27658422
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA‑518b functions as a tumor suppressor in glioblastoma by targeting PDGFRB.
Xu X; Zhang F; Chen X; Ying Q
Mol Med Rep; 2017 Oct; 16(4):5326-5332. PubMed ID: 28849154
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of EZH2 reverses chemotherapeutic drug TMZ chemosensitivity in glioblastoma.
Fan TY; Wang H; Xiang P; Liu YW; Li HZ; Lei BX; Yu M; Qi ST
Int J Clin Exp Pathol; 2014; 7(10):6662-70. PubMed ID: 25400745
[TBL] [Abstract][Full Text] [Related]
15. Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors.
Wang Z; Yang J; Xu G; Wang W; Liu C; Yang H; Yu Z; Lei Q; Xiao L; Xiong J; Zeng L; Xiang J; Ma J; Li G; Wu M
Oncotarget; 2015 Feb; 6(5):3147-64. PubMed ID: 25605243
[TBL] [Abstract][Full Text] [Related]
16. Interaction between transcription factors PAX6/PAX6-5a and specific members of miR-183-96-182 cluster, may contribute to glioma progression in glioblastoma cell lines.
Pavlakis E; Tonchev AB; Kaprelyan A; Enchev Y; Stoykova A
Oncol Rep; 2017 Mar; 37(3):1579-1592. PubMed ID: 28184912
[TBL] [Abstract][Full Text] [Related]
17. PAX6 suppresses the invasiveness of glioblastoma cells and the expression of the matrix metalloproteinase-2 gene.
Mayes DA; Hu Y; Teng Y; Siegel E; Wu X; Panda K; Tan F; Yung WK; Zhou YH
Cancer Res; 2006 Oct; 66(20):9809-17. PubMed ID: 17047041
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneous glioblastoma cell cross-talk promotes phenotype alterations and enhanced drug resistance.
Motaln H; Koren A; Gruden K; Ramšak Ž; Schichor C; Lah TT
Oncotarget; 2015 Dec; 6(38):40998-1017. PubMed ID: 26517510
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus-mediated transfer of siRNA against basic fibroblast growth factor mRNA enhances the sensitivity of glioblastoma cells to chemotherapy.
Feng X; Zhang B; Wang J; Xu X; Lin N; Liu H
Med Oncol; 2011 Mar; 28(1):24-30. PubMed ID: 20221717
[TBL] [Abstract][Full Text] [Related]
20. JSI-124 inhibits glioblastoma multiforme cell proliferation through G(2)/M cell cycle arrest and apoptosis augment.
Su Y; Li G; Zhang X; Gu J; Zhang C; Tian Z; Zhang J
Cancer Biol Ther; 2008 Aug; 7(8):1243-9. PubMed ID: 18487947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
